Organigram Reports Second Quarter Fiscal 2026 Results

About this update from Organigram Global Inc.

TORONTO, May 12, 2026--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1, is pleased to announce its results for the second quarter ended March 31, 2026 ("Q2 Fiscal 2026" or "Q2"). Q2 FISCAL 2026 HIGHLIGHTS "Q2 reflected our underperformance in vapes and temporary challenges in infused pre-roll production, compounded by slower industry growth," said James Yamanaka, CEO of Organigram. "We acted quickly to address these issues, and the operational changes and product enhancements we have implemented are already beginning to stabilize performance. Combined with continued improvements in yields and flower potency, and the contribution from Sanity Group beginning in Q3, we believe the business is positioned for stronger execution and improved performance in the second half of fiscal 2026." SECOND QUARTER FISCAL 2026 FINANCIAL OVERVIEW "The financial impact of the competitive and operational challenges encountered earlier in Fiscal 2026 is believed to have been largely realized in the first half of the year, and we are now beginning to see performance stabilize," said Greg Guyatt, Chief Financial Officer of Organigram. "While margins and profitability were pressured during the quarter, the underlying cost structure of the business continues to improve, supported by higher yields, operational efficiencies, and prior investments in automation. We expect to resume our trajectory of margin expansion and profitability improvement through the second half of the year, supported by expected growth in net revenue and international sales, alongside positive contributions from the consolidation of Sanity Group." INTERNATIONAL SALES BALANCE SHEET & LIQUIDITY FISCAL 2026 GUIDANCE RECONCILIATION The following table reconciles the Company's adjusted EBITDA to net income (loss). The following table reconciles the Company's adjusted gross margin to gross margin before fair value adjustments: The following table reconciles the Company's Free Cash Flow to net cash and restricted cash provided by (used in) operating activities: Second Quarter Fiscal 2026 Conference Call The Company will host a conference call to discuss its results with details as follows:Date: May 12, 2026Time: 8:00 am Ea...

View stock analysis, news, and events for Organigram Global Inc.